FinEdge Labs
M

MRK

MRKUnverified
2 segments tracked|7 years of data|Annual (10-K)
Total Revenue
$18.6B17.6%
FY2024
Operating Segments
2
Active segments
Blended Margin
0.0%
Operating margin
Highest Margin
0.0%
Pharmaceuticalsegment
Segment Shift

Pharmaceuticalsegment has grown from 100.0% to 96.1% of total revenue since FY2014, with 0.0% operating margins.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2024

SegmentRevenueOp. IncomeMargin% of TotalYoY
Pharmaceuticalsegment$17.9B$00.0%96.1%+18.2%
Animal Healthsegment$732M$00.0%3.9%+4.6%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free